{"nct_id":"NCT04041050","title":"A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-06","start_date":"2019-11-08","start_date_type":"ACTUAL","primary_completion_date":"2026-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12-31","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ABBV"]}